XML 47 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Farmers Capital Bank Corporation [Member]
First Sentry Bancshares, Inc. [Member]
Common Stock [Member]
Common Stock [Member]
Farmers Capital Bank Corporation [Member]
Common Stock [Member]
First Sentry Bancshares, Inc. [Member]
Capital Surplus [Member]
Capital Surplus [Member]
Farmers Capital Bank Corporation [Member]
Capital Surplus [Member]
First Sentry Bancshares, Inc. [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Farmers Capital Bank Corporation [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Deferred Benefits for Directors [Member]
Beginning Balance at Dec. 31, 2017 $ 1,395,321     $ 91,756     $ 684,730     $ 651,357     $ (31,495) $ (1,027)
Beginning Balance, shares at Dec. 31, 2017       44,043,244                    
Net income 99,184                 99,184        
Other Comprehensive Income (Loss) (27,315)                       (27,315)  
Comprehensive income 71,869                          
Common dividends declared (42,127)                 (42,127)        
Adoption of accounting standard ASU 2016-01                   1,063     (1,063)  
Shares issued for acquisition   $ 391,267 $ 107,347   $ 16,487 $ 5,206   $ 374,464 $ 102,141     $ 316    
Shares issued for acquisition, shares         7,920,387 2,498,761                
Treasury shares acquired (696)           34       $ (730)      
Treasury shares acquired, shares       (15,489)                    
Restricted stock granted       $ 205     (205)              
Restricted stock granted, shares       98,301                    
Stock compensation expense 2,933           2,933              
Deferred benefits for directors- net (494)           (437)             (57)
Ending Balance at Sep. 30, 2018 1,927,269     $ 113,758     1,165,006     709,477 (15)   (59,873) (1,084)
Ending Balance, shares at Sep. 30, 2018       54,603,967                    
Stock options exercised 1,849     $ 104     1,346       399      
Stock options exercised, shares       58,763                    
Beginning Balance at Jun. 30, 2018 1,524,106     $ 97,197     789,038     692,820 (555)   (53,352) (1,042)
Beginning Balance, shares at Jun. 30, 2018       46,643,250                    
Net income 32,486                 32,486        
Other Comprehensive Income (Loss) (6,521)                       (6,521)  
Comprehensive income 25,965                          
Common dividends declared (15,829)                 (15,829)        
Shares issued for acquisition   $ 391,267     $ 16,487     $ 374,465       $ 315    
Shares issued for acquisition, shares         7,920,387                  
Treasury shares acquired (15)                   (15)      
Treasury shares acquired, shares       (330)                    
Restricted stock granted       $ 39     (39)              
Restricted stock granted, shares       18,685                    
Stock compensation expense 1,094           1,094              
Deferred benefits for directors- net (25)           17             (42)
Ending Balance at Sep. 30, 2018 1,927,269     $ 113,758     1,165,006     709,477 (15)   (59,873) (1,084)
Ending Balance, shares at Sep. 30, 2018       54,603,967                    
Stock options exercised 706     $ 35     431       240      
Stock options exercised, shares       21,975                    
Beginning Balance at Dec. 31, 2018 1,978,827     $ 113,758     1,166,701     737,581 (274)   (37,871) (1,068)
Beginning Balance, shares at Dec. 31, 2018       54,598,134                    
Net income 122,497                 122,497        
Other Comprehensive Income (Loss) 47,793                       47,793  
Comprehensive income 170,290                          
Common dividends declared (50,746)                 (50,746)        
Treasury shares acquired (797)           170       (967)      
Treasury shares acquired, shares       (26,358)                    
Restricted stock granted       $ 188     (1,076)       888      
Restricted stock granted, shares       113,449                    
Stock compensation expense 3,772           3,772              
Deferred benefits for directors- net (198)           16             (214)
Ending Balance at Sep. 30, 2019 2,101,269     $ 113,954     1,169,595     809,332 (252)   9,922 (1,282)
Ending Balance, shares at Sep. 30, 2019       54,691,225                    
Stock options exercised 121     $ 8     12       101      
Stock options exercised, shares       6,000                    
Beginning Balance at Jun. 30, 2019 2,074,116     $ 113,952     1,168,212     788,900 (2)   4,113 (1,059)
Beginning Balance, shares at Jun. 30, 2019       54,697,199                    
Net income 37,347                 37,347        
Other Comprehensive Income (Loss) 5,809                       5,809  
Comprehensive income 43,156                          
Common dividends declared (16,915)                 (16,915)        
Treasury shares acquired (208)           42       (250)      
Treasury shares acquired, shares       (6,974)                    
Restricted stock granted       $ 2     (2)              
Restricted stock granted, shares       1,000                    
Stock compensation expense 1,333           1,333              
Deferred benefits for directors- net (213)           10             (223)
Ending Balance at Sep. 30, 2019 $ 2,101,269     $ 113,954     $ 1,169,595     $ 809,332 $ (252)   $ 9,922 $ (1,282)
Ending Balance, shares at Sep. 30, 2019       54,691,225